H&R Block (NYSE:HRB) Lowered to “Hold” at StockNews.com
StockNews.com cut shares of H&R Block (NYSE:HRB – Free Report) from a buy rating to a hold rating in a research report released on Thursday...
Cerevel Therapeutics (NASDAQ:CERE) Downgraded to Neutral at Cantor Fitzgerald
Cantor Fitzgerald cut shares of Cerevel Therapeutics (NASDAQ:CERE – Free Report) from an overweight rating to a neutral rating in a report issued on Thursday,...
Braze (NASDAQ:BRZE) Given New $65.00 Price Target at DA Davidson
Braze (NASDAQ:BRZE – Free Report) had its price target boosted by DA Davidson from $53.00 to $65.00 in a research report released on Thursday, Benzinga...
Braze (NASDAQ:BRZE) Price Target Raised to $75.00 at Raymond James
Braze (NASDAQ:BRZE – Free Report) had its target price raised by Raymond James from $52.00 to $75.00 in a report issued on Thursday morning, Benzinga...
Fanhua (NASDAQ:FANH) Rating Lowered to Sell at StockNews.com
StockNews.com lowered shares of Fanhua (NASDAQ:FANH – Free Report) from a hold rating to a sell rating in a report released on Thursday. Fanhua Price...
Mizuho Boosts EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target to $30.00
EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) had its target price boosted by Mizuho from $20.00 to $30.00 in a research report released on Thursday morning,...